Workflow
医美能量源产品
icon
Search documents
伟思医疗近10个交易日累计上涨22.0%
Sou Hu Cai Jing· 2025-08-15 08:15
来源:金融界 伟思医疗主营业务:主要从事医疗器械的研发、生产和销售,以研发创新为发展驱动力,持续投入在电刺 激、磁刺激、电生理、康复机器人以及医美能量源等方向的先进技术研发,并完善产品布局。公司致力 于在磁刺激领域成为全球领先供应商,在康复领域和医美领域成为中国领先供应商,正在探索海外市场以 及TMS治疗抑郁症技术及创新模式。 截至2025年3月31日,伟思医疗实现营业总收入9591.27万元,同比增长9.40%,实现归属净利润3322.01 万元,同比增长52.71%。流动比率、速动比率分别为7.579、7.341,资产负债率为8.47%。 8月15日收盘,伟思医疗当日上涨1.82%,成交额1.98亿元,换手率3.74%。从区间来看,该股近10个交 易日累计上涨22.0%。 资金流向方面,今日主力资金净流出546.86万元,占成交比2.76%,其中超大单净流入334.22万元,占 成交比1.69%。 ...
伟思医疗(688580)7月16日主力资金净买入967.38万元
Sou Hu Cai Jing· 2025-07-17 00:28
Group 1 - The stock price of Weisi Medical (688580) closed at 46.98 yuan on July 16, 2025, with an increase of 2.26% and a trading volume of 22,900 hands, resulting in a transaction amount of 106 million yuan [1] - On July 16, the net inflow of main funds was 9.67 million yuan, accounting for 9.09% of the total transaction amount, while retail investors had a net outflow of 4.53 million yuan, accounting for 4.25% [1][2] - The financing data shows that on July 16, the financing balance was 176 million yuan, with a net repayment of 5.61 million yuan [2][3] Group 2 - Weisi Medical's Q1 2025 report indicates a main revenue of 95.91 million yuan, a year-on-year increase of 9.4%, and a net profit of 33.22 million yuan, a year-on-year increase of 52.71% [5] - The company has a total market value of 4.499 billion yuan, with a net asset of 1.662 billion yuan and a net profit of 33.22 million yuan, ranking 75th, 82nd, and 51st respectively in the medical device industry [5] - The company aims to become a global leader in the magnetic stimulation field and a leading supplier in the rehabilitation and medical aesthetics sectors in China, while exploring overseas markets [5] Group 3 - Over the past 90 days, 9 institutions have rated the stock, with 6 buy ratings and 3 hold ratings, and the average target price set at 55.12 yuan [6] - The company maintains a gross profit margin of 66.65%, significantly higher than the industry average of 51.08%, and a net profit margin of 34.64%, compared to the industry average of 10.86% [5] - The company is focused on R&D in advanced technologies such as electrical stimulation, magnetic stimulation, electrophysiology, rehabilitation robots, and medical energy sources [5]